Recent research highlights the growing interest in bacteriophages, or phages, as potential alternatives to traditional antibiotics in veterinary settings. This shift comes amid rising concerns about antimicrobial resistance, which threatens the efficacy of many existing treatments.
Jeroen De Buck, a veterinary microbiologist at the University of Calgary, has been investigating Johne’s disease in cattle, a challenging condition caused by Mycobacterium avium subspecies paratuberculosis. Antibiotics typically struggle to penetrate the pathogen’s thick cell wall. Though vaccines are available, they often lack effectiveness. In response, De Buck and his team have turned to phages — viruses that specifically target and kill bacteria.
The research team isolated various phages from environmental samples across Alberta dairy farms, leading to promising developments. Their findings suggest that phage-based treatments could serve as a preventive measure against Johne’s disease. This approach aligns with a broader global movement toward phage therapy, which has seen limited use in Europe, Brazil, and the US for controlling pathogens like Listeria and Salmonella in livestock.
Phages offer unique advantages over antibiotics, primarily their specificity. Each type of phage targets a specific bacterium, minimizing the risk of disrupting beneficial microbiota, a common problem with antibiotics. However, this specificity also poses challenges, as it requires precise identification of suitable phages for each bacterial strain. Researchers are exploring phage cocktails — combinations of multiple phages — to combat potential bacterial resistance.
Recently, phage therapy has made headlines beyond food animals. In a pioneering case, a cat infected with a drug-resistant Pseudomonas aeruginosa was treated successfully with phages, demonstrating their potential in companion animal medicine.
Despite the promise of phages, challenges remain, including regulatory hurdles and the need for comprehensive safety assessments. As research progresses, the veterinary community may see phages as a valuable tool in combating resistant bacterial infections, complementing traditional antibiotic therapies rather than replacing them altogether.
Overall, the advent of phage therapy signals a pivotal moment in veterinary medicine, offering a novel approach to managing infections that resist conventional treatments.
